Copyright: ©Author(s) 2026.
World J Gastroenterol. Aug 14, 2026; 32(30): 117778
Published online Aug 14, 2026. doi: 10.3748/wjg.117778
Published online Aug 14, 2026. doi: 10.3748/wjg.117778
Figure 1 Allocation of patients.
A: In the GASTRODOC trial; B: The long-term results. AE: Adverse event; RFS: Relapse-free survival.
Figure 2
Inverse Kaplan-Meier representing cumulative proportion of patients with disease recurrence (n = 41).
Figure 3 Kaplan-Meier curves.
A: Representing relapse-free survival by arm and 95% confidence interval (n = 84); B: Representing overall survival by arm and 95%confidence interval (n = 86).
- Citation: Monti M, Ceredi B, Foca F, Morgagni P, Framarini M, Vertogen B, Marrelli D, Roviello F, Fumagalli Romario U, Bozzarelli S, Donini A, Graziosi L, Filippini F, Bencivenga M, Milandri C, Mura G, Baiocchi GL, Rausei S, Molinari C, Passardi A. When and where: A study on gastric cancer recurrence after neoadjuvant/perioperative chemotherapy. World J Gastroenterol 2026; 32(30): 117778
- URL: https://www.wjgnet.com/1007-9327/full/v32/i30/117778.htm
- DOI: https://dx.doi.org/10.3748/wjg.117778